Endothelial function: Ready for prime time?

被引:0
作者
Verma, S
Szmitko, PE
Anderson, TJ
机构
[1] Univ Toronto, Div Cardiac Surg, Toronto, ON, Canada
[2] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada
[3] Univ Calgary, Dept Cardiovasc Sci, Calgary, AB, Canada
[4] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada
关键词
atherosclerosis; biomarker; C-reactive protein; endothelial function; endothelium;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The strategic location of the endothelium allows it to detect changes in hemodynamic forces and blood-borne signals, and to respond by releasing a number of autocrine and paracrine substances. The balanced release of these bioactive factors facilitates vascular homeostasis. If disrupted, endothelial cell dysfunction ensues. This predisposes the vessel wall to vasoconstriction, leukocyte adherence, platelet activation, thrombosis, vascular inflammation and atherosclerosis. Given the central role of the endothelium in the development and progression of atherosclerosis, endothelial function testing may serve as a useful biomarker of atherosclerotic disease. The present review highlights the current modalities used in assessing endothelial function, explores how endothelial function may serve as a biomarker for atherosclerosis, comments on the prognostic relevance of endothelial function and describes its use in the clinical setting.
引用
收藏
页码:1335 / 1339
页数:5
相关论文
共 50 条
  • [1] Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
    Al Suwaidi, J
    Hamasaki, S
    Higano, ST
    Nishimura, RA
    Holmes, DR
    Lerman, A
    [J]. CIRCULATION, 2000, 101 (09) : 948 - 954
  • [2] Anderson TJ, 2003, CAN J CARDIOL, V19, P61
  • [3] CLOSE RELATION OF ENDOTHELIAL FUNCTION IN THE HUMAN CORONARY AND PERIPHERAL CIRCULATIONS
    ANDERSON, TJ
    UEHATA, A
    GERHARD, MD
    MEREDITH, IT
    KNAB, S
    DELAGRANGE, D
    LIEBERMAN, EH
    GANZ, P
    CREAGER, MA
    YEUNG, AC
    SELWYN, AP
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) : 1235 - 1241
  • [4] Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
    Anderson, TJ
    Elstein, E
    Haber, H
    Charbonneau, F
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) : 60 - 66
  • [5] Abciximab attenuates coronarv microvascular endothelial dysfunction after coronary stenting
    Aymong, ED
    Curtis, MJ
    Youssef, M
    Graham, MM
    Shewchuk, L
    Leschuk, W
    Anderson, TJ
    [J]. CIRCULATION, 2002, 105 (25) : 2981 - 2985
  • [6] BRISTER SJ, 1997, ADV EXP MED BIOL, V423, P275
  • [7] Endothelial function predicts future development of coronary artery disease - A study of women with chest pain and normal coronary angiograms
    Bugiardini, R
    Manfrini, O
    Pizzi, C
    Fontana, F
    Morgagni, G
    [J]. CIRCULATION, 2004, 109 (21) : 2518 - 2523
  • [8] Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force
    Corretti, MC
    Anderson, TJ
    Benjamin, EJ
    Celermajer, D
    Charbonneau, F
    Creager, MA
    Deanfield, J
    Drexler, H
    Gerhard-Herman, M
    Herrington, D
    Vallance, P
    Vita, J
    Vogel, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) : 257 - 265
  • [9] CORRETTI MC, 2002, J AM COLL CARDIOL, V39, P1082
  • [10] Increased thrombosis after arterial injury in human C-reactive protein - Transgenic mice
    Danenberg, HD
    Szalai, AJ
    Swaminathan, RV
    Peng, L
    Chen, ZP
    Seifert, P
    Fay, WP
    Simon, DI
    Edelman, ER
    [J]. CIRCULATION, 2003, 108 (05) : 512 - 515